Showing results (681-690 of 6,952) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|June 24, 2003
Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinideVibeke Hatorp, Kristian T Hansen, Mikael S ThomsenJournal of Clinical Pharmacology|July 15, 2003
Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteersEytan A Klausner, Eran Lavy, David Stepensky, et al.Journal of Clinical Pharmacology|July 15, 2003
Safety, pharmacokinetics, and pharmacodynamics of E5564, a lipid A antagonist, during an ascending single-dose clinical studyY Nancy Wong, Daniel Rossignol, Jeffrey R Rose, et al.Journal of Clinical Pharmacology|April 1, 1976
Naproxen plasma levels in volunteers after single-dose administration by oral and rectal routesJ P Desager, M Vanderbist, C HarvengtJournal of Clinical Pharmacology|September 5, 2003
Using multiple drug exposure levels to optimize power in pharmacogenetic trialsRichard JudsonJournal of Clinical Pharmacology|July 1, 1992
Effects of a long-term treatment with alacepril on left ventricular hypertrophy and function in patients with essential hypertensionT Sumimoto, T Ochi, K HiwadaJournal of Clinical Pharmacology|June 1, 1992
Terazosin: a new alpha adrenoceptor blocking drugR Achari, A LadduJournal of Clinical Pharmacology|October 1, 2003
An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probeKenneth Bachmann, Donald White, Luis Jauregui, et al.Journal of Clinical Pharmacology|October 1, 2003
Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenemJoseph L Kuti, Prachi K Dandekar, Charles H Nightingale, et al.Pageof 696